Finally, we constructed a nomogram, a predictive tool that amalgamates various prognostic factors, such as gender, age, and histological features, along with SHANK2 expression levels, to estimate the survival probabilities for glioma patients (Figure 5(a)). The gene discussed is SHANK2; the disease is central nervous system cancer.